An investigation of aminoglutethimide cytotoxicity and its role in activation of cell death signaling pathways

• Author / Creator

  Baghdasarian, Argishti

• Aminoglutethimide (AG), a drug used for the treatment of breast and ovarian cancers, is known to cause toxicities such as agranulocytosis. To investigate its toxicity mechanisms, we have used quantitative proteomic analysis to gain insight into the proteome of Human Leukemia 60 (HL-60) treated with AG. We identified 43 proteins that were changed significantly upon AG treatment among which 18 (42%) and 25 (58%) were up and down-regulated, respectively. The quantitative proteomics data showed that AG treatment led to the down-regulation of critical anti-apoptotic proteins responsible for inhibiting the release of pro-apoptotic factors from the mitochondria as well as cytoskeletal proteins such as nuclear lamina. This overall pro-apoptotic response was confirmed with flow cytometry which demonstrated apoptosis to be the main factor of cell death. This response correlated with the intensity of AG-induced protein radical formation in HL-60 cells, which may have an important role in cell death signaling mechanisms.

• Subjects / Keywords

  • Proteomics
  • SILAC
  • Aminoglutethimide
  • HL-60 cells
  • Drug-induced agranulocytosis
  • Apoptosis
  • Free radicals
  • Idiosyncratic drug reactions

• Graduation date

  Fall 2013

• Type of Item

  Thesis

• Degree

  Master of Science

• DOI

  https://doi.org/10.7939/R39S1KW71

• License

  This thesis is made available by the University of Alberta Libraries with permission of the copyright owner solely for non-commercial purposes. This thesis, or any portion thereof, may not otherwise be copied or reproduced without the written consent of the copyright owner, except to the extent permitted by Canadian copyright law.